U.S. markets close in 3 hours 25 minutes

  • S&P 500

    3,917.05
    -6.63 (-0.17%)
     

  • Dow 30

    31,270.87
    -219.20 (-0.70%)
     

  • Nasdaq

    11,495.98
    +77.83 (+0.68%)
     

  • Russell 2000

    1,790.67
    +15.82 (+0.89%)
     

  • Crude Oil

    110.16
    +0.57 (+0.52%)
     

  • Gold

    1,841.50
    +25.60 (+1.41%)
     

  • Silver

    21.86
    +0.32 (+1.49%)
     

  • EUR/USD

    1.0598
    +0.0132 (+1.2611%)
     

  • 10-Yr Bond

    2.8420
    -0.0440 (-1.52%)
     

  • Vix

    30.01
    -0.95 (-3.07%)
     

  • GBP/USD

    1.2505
    +0.0163 (+1.3180%)
     

  • USD/JPY

    127.6020
    -0.6950 (-0.5417%)
     

  • BTC-USD

    30,255.29
    +1,294.27 (+4.47%)
     

  • CMC Crypto 200

    673.74
    +21.50 (+3.30%)
     

  • FTSE 100

    7,302.74
    -135.35 (-1.82%)
     

  • Nikkei 225

    26,402.84
    -508.36 (-1.89%)
     

Insights on the Voice Assisted Technology in Healthcare Global Market to 2027 - Featuring AdventHealth, Apple and Kiroku Among Others - ResearchAndMarkets.com

·4 min read

DUBLIN, January 21, 2022--(BUSINESS WIRE)--The "Voice Assisted Technology in Healthcare Market Research Report by Module, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Voice Assisted Technology in Healthcare Market size was estimated at USD 218.66 million in 2020, is expected to reach USD 262.27 million in 2021, and is projected to grow at a CAGR of 20.30% to reach USD 797.67 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Voice Assisted Technology in Healthcare Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Voice Assisted Technology in Healthcare Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Voice Assisted Technology in Healthcare Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Voice Assisted Technology in Healthcare Market?

4. What is the competitive strategic window for opportunities in the Global Voice Assisted Technology in Healthcare Market?

5. What are the technology trends and regulatory frameworks in the Global Voice Assisted Technology in Healthcare Market?

6. What is the market share of the leading vendors in the Global Voice Assisted Technology in Healthcare Market?

7. What modes and strategic moves are considered suitable for entering the Global Voice Assisted Technology in Healthcare Market?

Market Dynamics

Drivers

  • Rise of voice recognition technology for patient engagement and reduced administrative workloads

  • Importance of AI on digital assistance and Internet-enabled thermostats

  • Increasing application in diagnosis and tracking of disease progression to improve care plans

  • Attractive funding and investments raised by start-ups

Restraints

  • Issue of noncompliance with HIPAA

  • Issues related to security, reliability, and logistics

Opportunities

  • Ongoing experimental pilot programs

  • Voice chatbots with AI capabilities to provide real-time support

  • Potential adoption among physicians and patients

Challenges

  • Complicated implementation of voice-assisted technology in healthcare

Companies Mentioned

  • Advanced Voice Recognition Systems, Inc.

  • AdventHealth

  • Aiva Health

  • Allscripts Healthcare Solutions, Inc.

  • Amazon.com, Inc.

  • Apple Inc.

  • Auraya Systems Pty Ltd.

  • Baidu, Inc.

  • CSS Corporation

  • Fujitsu Frontech North America Inc.

  • IBM Corporation

  • Kiroku

  • Microsoft Corporation

  • Northwell Health

  • Nuance Communications

  • Orbita, Inc.

  • Piedmont Healthcare

  • PulsePoint, Inc.

  • Samsung Group

  • Sensory Inc.

  • Sopris Health

  • Suki

  • True Image Interactive, Inc.

  • Verint systems

  • Welltok, Inc

For more information about this report visit https://www.researchandmarkets.com/r/v5cp70

View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005176/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Recommended Stories

  • Down Almost 70%, SoFi Technologies' CEO Keeps Buying Shares

    Investor sentiment has cratered in recent times in the wake of 40-year-high inflation, the Federal Reserve's decision to raise interest rates in response, and prolonged concerns in connection to Russia's invasion of Ukraine. With investors flocking to value stocks and safer assets for protection, shares of fast-growing technology companies have been especially crushed. The company's pullback has attracted the attention of CEO Anthony Noto.

  • This is how much money Americans think they need to be considered wealthy

    Charles Schwab's annual Modern Wealth Survey also asked 1,000 Americans how much they needed in order to live comfortably.

  • Markets haven’t acted like this since 1981 — and here’s how that played out

    The simultaneous decline of multiple asset classes is unusual. Here's what bottomed first 40 years ago.

  • Will Novavax Stock Ever Reach Its All-Time High Again?

    Novavax (NASDAQ: NVAX) investors are no strangers to tragedy. On Feb. 9 in 2021, shares of the coronavirus vaccine developer hit their all-time high of $331.68. Are longtime shareholders doomed to heavy losses forever, or will Novavax return to its glory days?

  • Cisco reports big revenue miss, cuts full-year guidance

    Yahoo Finance's Jared Blikre joins the Live show to check out Cisco's mixed Q3 earnings report.

  • Can This Cancer Stock Maintain Its Momentum?

    The stock market continues to be under pressure due to geopolitical tensions and various economic problems. For instance, cancer-focused biotech company Exelixis (NASDAQ: EXEL) has run circles around the broader market year to date. Can Exelixis continue beating the market from here on out?

  • Cisco stock hits 52-week low following earnings

    Yahoo Finance Live anchors discuss Cisco shares hitting a 52-week low.

  • Why You May Regret Not Buying AMD Stock Right Now

    Shares of Advanced Micro Devices (NASDAQ: AMD) are down 29% in 2022, but there are no signs of a slowdown in the company's growth. The latest market-share numbers for the x86 processor space (which includes processors that are used in computers, servers, consoles, and Internet of Things devices) from Mercury Research tell us just why AMD has been putting up healthy growth quarter after quarter. AMD once again took business away from Intel (NASDAQ: INTC) in the first quarter of 2022 in key areas that sent its x86 market share to a record high.

  • Here’s Why Vulcan Value Partners Reduced its Upstart (UPST) Stake

    Vulcan Value Partners, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be downloaded here. All five of the fund’s strategies trailed their respective benchmarks during the quarter. According to the fund, they ‘place no weight on short-term results, good or bad, and neither should you’. Vulcan Value […]

  • Tesla bull Dan Ives cuts the stock's price target to $1,000 from $1,400

    Yahoo Finance's Brian Sozzi discusses why Wedbush analyst Dan Ives cut his price target on Tesla.

  • 10 Best Stocks to Buy Now According to Billionaire Ken Fisher

    In this article, we discuss 10 stocks to buy now according to billionaire Ken Fisher. If you want to skip our detailed analysis of Fisher’s history, investment philosophy, and hedge fund performance, go directly to 5 Best Stocks to Buy Now According to Billionaire Ken Fisher. Ken Fisher is a billionaire hedge fund manager and […]

  • Warren Buffett Just Bought Lots of Stocks -- Here's the One I'm Most Excited About

    Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) recently filed its latest 13-F with the SEC, giving investors a look at the stocks that the Warren Buffett-led conglomerate bought during the first quarter. It turns out Buffett and his team started eight new stock positions. What does Markel do?

  • Shopify's Net Losses in Q1 2022 Are Not Because of Fulfillment Network

    Now investors can add one more item to the list of concerns: Shopify reported a $1.47 billion net loss in Q1 2022, compared to a $1.26 billion net profit a year ago. During the full-year 2021 financial update a few months ago, Shopify outlined how it would ramp up its investment in its shipping and logistics segment Shopify Fulfillment Network (SFN) in the next couple of years. This concerned some shareholders as Shopify continuously moves away from its ultra-asset-light and profitable e-commerce software business as it tries to woo over more merchants from platforms like Amazon.

  • Warren Buffett Is Holding These 10 Tech Stocks Despite Selloff

    In this article, we discuss 10 tech stocks Warren Buffett is holding despite selloff. If you want to see more tech stocks held by the billionaire amid the broader market selloff, click Warren Buffett Is Holding These 5 Tech Stocks Despite Selloff. Warren Buffett’s portfolio is often replicated by aspiring retail investors, as well as […]

  • Is Ocugen Finally on the Way to Vaccine Revenue?

    Last year, Ocugen (NASDAQ: OCGN) shares soared more than 700% over just a few days. The company signed an agreement to co-commercialize Bharat Biotech's coronavirus vaccine in the U.S. The companies later added rights in Canada to the agreement too. Bharat's product -- Covaxin -- already had gained emergency authorization in its home country of India.

  • Is Nvidia Stock a Buy Now?

    In particular, Nvidia (NASDAQ: NVDA) has seen its stock price drop by 48%. The fall, understandably, has many investors asking if it's a good idea to buy Nvidia stock right now. Let's look closer at Nvidia's prospects, balance that with its valuation, and determine if long-term investors should buy now.

  • Billionaires like Jeff Bezos and Bill Gates are making big bets on farmland — here are 2 effortless ways you can access it, too

    Inflation is running hot. Farmland can help your portfolio with that.

  • Goldman Sachs Says Buy These 2 Dividend Stocks; Here’s Why

    Since early this year, Wall Street has faced a storm of macro headwinds that have turned last year’s bullish run into a bearish trend. Year-to-date, the NASDAQ is down 27%, and the S&P, with a loss of 18%, is not far behind. The drop in the markets comes along with gains in Treasury bonds – the 10-year Treasury note rate is nearly up to 2.9%. In a thumbnail summary, we can say that last year, investors looked at the markets through TINA’s (there is no alternative) eyes; now, conditions are start

  • The Best Stocks to Buy With $100 Right Now

    Shares in these companies were trading above $300 in 2021 and they have what it takes to return to those levels in time.

  • Nasdaq Bear Market: 2 Excellent Bargains for Investors

    Growth stocks are especially feeling the brunt of the market's sell-off, and as of this writing, the tech-heavy Nasdaq Composite index is down over 27% from its all-time high, comfortably past the bear market threshold of 20%. Two such businesses with excellent fundamentals are Datadog (NASDAQ: DDOG) and MercadoLibre (NASDAQ: MELI). Let's see why overlooking these promising businesses now could turn out to be a missed opportunity.